William Ringo
Chairman at ASSEMBLY BIOSCIENCES, INC.
Net worth: 42 838 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jason Okazaki | M | 48 | 4 years | |
| Susan Mahony | M | 59 |
Kovina Therapeutics, Inc.
 Kovina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kovina Therapeutics, Inc. is a pre-clinical stage biotechnology company based in Indianapolis, IN. The company has assembled a team of scientists and industry leaders with expertise in HPV and small molecule drug design to advance its pipeline of drug candidates. Kovina Therapeutics is developing first-in-class anti-viral therapeutics to treat human papillomavirus (HPV) related infections and associated cancers. The company was founded by Samy Meroueh, Zhijian Lu, Elliot Androphy. Kristin T. Sherman has been the CEO of the company since 2021. | 24 years |
| Kevin Hammons | M | 58 | 27 years | |
| David Ricks | M | 56 | 28 years | |
| Wayne Smith | M | 78 | 27 years | |
| Bruce Given | M | 69 |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX.
InCube Venture Partners LLC
 InCube Venture Partners LLC Investment ManagersFinance InCube Ventures Partners LLC (InCube Ventures) is a venture capital firm founded in 2008 by Mir Imran. The firm is headquartered in San Jose, California. | 10 years |
| John McHutchison | M | 66 | 5 years | |
| Toby Wilson Waterworth | M | - |
Atlantic Healthcare Plc
 Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | 18 years |
| Caroline Litchfield | F | 55 | 5 years | |
| Erin Colgan | F | 43 | 4 years | |
| Alexander Macrae | M | 61 | 8 years | |
| Rita Karachun | F | 63 | 5 years | |
| John Celebi | M | 52 | 6 years | |
| Elliot Androphy | M | - |
Kovina Therapeutics, Inc.
Kovina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kovina Therapeutics, Inc. is a pre-clinical stage biotechnology company based in Indianapolis, IN. The company has assembled a team of scientists and industry leaders with expertise in HPV and small molecule drug design to advance its pipeline of drug candidates. Kovina Therapeutics is developing first-in-class anti-viral therapeutics to treat human papillomavirus (HPV) related infections and associated cancers. The company was founded by Samy Meroueh, Zhijian Lu, Elliot Androphy. Kristin T. Sherman has been the CEO of the company since 2021. | - |
| H. Parker | F | 68 | 10 years | |
| Jessie English | M | 60 | 3 years | |
| Alonzo Weems | M | - | 27 years | |
| Lisa Johnson-Pratt | M | 60 | 3 years | |
| Kristian Humer | M | 49 | 3 years | |
| Zhijian Lu | M | - |
Kovina Therapeutics, Inc.
Kovina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kovina Therapeutics, Inc. is a pre-clinical stage biotechnology company based in Indianapolis, IN. The company has assembled a team of scientists and industry leaders with expertise in HPV and small molecule drug design to advance its pipeline of drug candidates. Kovina Therapeutics is developing first-in-class anti-viral therapeutics to treat human papillomavirus (HPV) related infections and associated cancers. The company was founded by Samy Meroueh, Zhijian Lu, Elliot Androphy. Kristin T. Sherman has been the CEO of the company since 2021. | - |
| John O. Gunderson | M | - | 2 years | |
| James Peyer | M | 37 | 4 years | |
| Heather Wasserman | M | - | 4 years | |
| Jon Filderman | M | - | 5 years | |
| Anat Ashkenazi | F | 51 | 23 years | |
| Christopher Gerry | M | - | 2 years | |
| Deneen Vojta | M | 59 | 4 years | |
| Edward van der Horst | M | 51 | 5 years | |
| Jeffrey R. Latts | M | 76 |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | 17 years |
| Edward W. Lomicka | M | - | 22 years | |
| Andrew Richard Boyce | M | 62 |
Atlantic Healthcare Plc
Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | 12 years |
| Gina Consylman | F | 52 | 4 years | |
| Earl Collier | M | 76 |
InCube Venture Partners LLC
InCube Venture Partners LLC Investment ManagersFinance InCube Ventures Partners LLC (InCube Ventures) is a venture capital firm founded in 2008 by Mir Imran. The firm is headquartered in San Jose, California. | - |
| Peter Hutt | M | 89 |
InCube Venture Partners LLC
InCube Venture Partners LLC Investment ManagersFinance InCube Ventures Partners LLC (InCube Ventures) is a venture capital firm founded in 2008 by Mir Imran. The firm is headquartered in San Jose, California. | - |
| Anthony Altig | M | 68 | 12 years | |
| Mir Imran | M | 67 |
InCube Venture Partners LLC
InCube Venture Partners LLC Investment ManagersFinance InCube Ventures Partners LLC (InCube Ventures) is a venture capital firm founded in 2008 by Mir Imran. The firm is headquartered in San Jose, California. | 17 years |
| Bob Holmen | M | 60 | 7 years | |
| Michael Houghton | M | 73 | 3 years | |
| Thomas Ricks | M | 70 | 9 years | |
| Andrew Farquharson | M | 55 |
InCube Venture Partners LLC
InCube Venture Partners LLC Investment ManagersFinance InCube Ventures Partners LLC (InCube Ventures) is a venture capital firm founded in 2008 by Mir Imran. The firm is headquartered in San Jose, California. | 17 years |
| Robert Carey | M | 65 | 8 years | |
| Kristin Sherman | F | - |
Kovina Therapeutics, Inc.
Kovina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kovina Therapeutics, Inc. is a pre-clinical stage biotechnology company based in Indianapolis, IN. The company has assembled a team of scientists and industry leaders with expertise in HPV and small molecule drug design to advance its pipeline of drug candidates. Kovina Therapeutics is developing first-in-class anti-viral therapeutics to treat human papillomavirus (HPV) related infections and associated cancers. The company was founded by Samy Meroueh, Zhijian Lu, Elliot Androphy. Kristin T. Sherman has been the CEO of the company since 2021. | 3 years |
| Martin G. Schweinhart | M | 68 | 27 years | |
| Jeanette Bjorkquist | F | - | 5 years | |
| William Delaney | M | 52 | 4 years | |
| Gary Thompson | M | - | 6 years | |
| Mark M. Sieczkarek | M | 69 |
InCube Venture Partners LLC
InCube Venture Partners LLC Investment ManagersFinance InCube Ventures Partners LLC (InCube Ventures) is a venture capital firm founded in 2008 by Mir Imran. The firm is headquartered in San Jose, California. | 9 years |
| Jennifer A. Troia | F | - | 7 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas Wiggans | M | 72 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 15 years |
| John Lechleiter | M | 70 | 38 years | |
| Aron M. Knickerbocker | M | 54 | 10 years | |
| Derek Small | M | 48 | 6 years | |
| Edward O. Lanphier | M | 67 | 22 years | |
| Brian Atwood | M | 71 | 14 years | |
| Lewis Williams | M | 74 | 18 years | |
| James Rickey | M | 45 | 6 years | |
| David Barrett | M | 48 | 8 years | |
| George Cole | M | 75 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 3 years |
| Daniel Welch | M | 66 | 12 years | |
| Mark McDade | M | 69 | 14 years | |
| Michael Samar | M | 51 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 6 years |
| Franklin Berger | M | 74 | 11 years | |
| Rachel A. Seifert | F | 63 | 19 years | |
| Russell Ellison | M | 76 | 5 years | |
| Lori Lyons-Williams | F | 46 | 5 years | |
| Luis Borges | M | 62 | 5 years | |
| Christopher Whitmore | M | - | 3 years | |
| Daljit Singh Aurora | M | 55 | 5 years | |
| Garry Nicholson | M | 69 | 12 years | |
| Uri Lopatin | M | 52 | 17 years | |
| R. Lee Douglas | M | 72 | 15 years | |
| Thomas Civik | M | 55 | 1 years | |
| David Lewis Miller | M | 74 | 19 years | |
| Pablo Cagnoni | M | 60 |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO.
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 5 years |
| Kapil Dhingra | M | 64 | 10 years | |
| Kathy Yi | F | 52 | 2 years | |
| Carlos Paya | M | 65 | 8 years | |
| Bryce D. Carmine | M | 72 | 29 years | |
| Amy Schulman | F | 63 | 6 years | |
| David McWilliams | M | 80 |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | 10 years |
| Randall L. Tobias | M | - | 12 years | |
| W. Cash | M | 75 | 20 years | |
| Joseph Zakrzewski | M | 60 | 22 years | |
| Freda Lewis-Hall | M | 69 | 20 years | |
| Matthew Fust | M | 59 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 11 years |
| David Baltimore | M | 86 | 22 years | |
| Martin Godbout | M | - | 12 years | |
| David J. Scott | M | 71 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
| Mark Gergen | M | 61 | 3 years | |
| Edward Penhoet | M | 83 | 11 years | |
| Francis Sarena | M | 53 | 11 years | |
| Richard DiMarchi | M | 71 | 21 years | |
| Henry Ward Wolff | M | 75 |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | 13 years |
| Graham Cooper | M | 54 | 1 years | |
| Sona Saira Ramasastry | F | 48 | 10 years | |
| Romulus Brazzell | M | 71 |
Inspire Pharmaceuticals, Inc.
 Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | 7 years |
| Wendell Wierenga | M | 76 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 17 years |
| Ronald J. Shafer | M | - | - | |
| Samuel Broder | M | 79 | 5 years | |
| Stephen Sherwin | M | 75 |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 98 | 98.00% |
| United Kingdom | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- William Ringo
- Personal Network
